Ranked #331 of 8,699 institutional investors
Baker Bros. Advisors LP
New York, NY
$19.97B
US stock portfolio at live prices · today +$71.9M (+0.36%)
Market closed. Prices as of Nov 20, 8:41 AM ET
- Value at quarter end (Q3 2026)
- $20.99B
- Change from Q2 2026
- +$1.10B (+5.55%)
- Positions
- 75 · 4 new, 6 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: $55.5M of convertible notes and other principal-amount securities. $788M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesINCY 17.8%ONC 17.7%KOD 10.7%RVMD 8.49%INSM 6.36%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| INCY Incyte Corporation | 30,762,652 | $3.56B | 17.8% | Unchanged |
| ONC BeOne Medicines AG | 8,832,335 | $3.53B | 17.7% | Added +0% |
| KOD Kodiak Sciences Inc. | 21,860,941 | $2.14B | 10.7% | Added +10% |
| RVMD Revolution Medicines, Inc. | 10,637,318 | $1.70B | 8.49% | Reduced −7% |
| INSM Insmed Incorporated | 8,796,111 | $1.27B | 6.36% | Unchanged |
| KYMR Kymera Therapeutics, Inc. | 8,657,242 | $1.03B | 5.18% | Unchanged |
| MDGL Madrigal Pharmaceuticals, Inc. | 2,143,131 | $850M | 4.26% | Unchanged |
| ACAD Acadia Pharmaceuticals Inc. | 42,912,904 | $755M | 3.78% | Unchanged |
| RYTM Rhythm Pharmaceuticals, Inc. | 5,604,483 | $655M | 3.28% | Unchanged |
| PRAX Praxis Precision Medicines, Inc. | 1,753,198 | $545M | 2.73% | Unchanged |
| GRAL GRAIL, Inc. | 4,028,614 | $422M | 2.11% | Unchanged |
| SMMT Summit Therapeutics Inc. | 32,786,348 | $347M | 1.74% | Unchanged |
| ABCL AbCellera Biologics Inc. | 33,012,139 | $346M | 1.73% | Unchanged |
| CELC Celcuity Inc. | 4,815,792 | $271M | 1.36% | Reduced −39% |
| REPL Replimune Group, Inc. | 11,045,336 | $212M | 1.06% | Unchanged |
| EWTX Edgewise Therapeutics, Inc. | 3,701,719 | $152M | 0.76% | Unchanged |
| IDYA IDEAYA Biosciences, Inc. | 5,010,030 | $131M | 0.66% | Unchanged |
| IMVT Immunovant, Inc. | 2,770,377 | $90.1M | 0.45% | Reduced −49% |
| ARWR Arrowhead Pharmaceuticals, Inc. | 1,709,053 | $74.6M | 0.37% | Reduced −14% |
| DNTH Dianthus Therapeutics, Inc. | 852,164 | $72.3M | 0.36% | Unchanged |
| CLDX Celldex Therapeutics, Inc. | 2,564,984 | $71.7M | 0.36% | Added +117% |
| DNLI Denali Therapeutics Inc. | 3,734,336 | $68.0M | 0.34% | Unchanged |
| NRIX Nurix Therapeutics, Inc. | 4,658,556 | $63.4M | 0.32% | Unchanged |
| RLAY Relay Therapeutics, Inc. | 2,826,783 | $45.0M | 0.23% | Unchanged |
| MIRM Mirum Pharmaceuticals, Inc. | 445,975 | $42.6M | 0.21% | Unchanged |
| ELVN Enliven Therapeutics, Inc. | 905,191 | $42.0M | 0.21% | Unchanged |
| GLUE Monte Rosa Therapeutics, Inc. | 4,345,736 | $38.7M | 0.19% | Unchanged |
| XNCR Xencor, Inc. | 1,102,106 | $37.5M | 0.19% | Unchanged |
| RAPP Rapport Therapeutics, Inc. | 1,547,090 | $36.5M | 0.18% | Unchanged |
| STOK Stoke Therapeutics, Inc. | 1,313,999 | $35.4M | 0.18% | Reduced −61% |
| BCYC Bicycle Therapeutics plc | 10,885,357 | $33.2M | 0.17% | Unchanged |
| PRLD Prelude Therapeutics Incorporated | 10,123,824 | $33.0M | 0.17% | Unchanged |
| IONS Ionis Pharmaceuticals, Inc. | 1,023,864 | $27.9M | 0.14% | Reduced −50% |
| DSGN Design Therapeutics, Inc. | 2,988,144 | $27.8M | 0.14% | Added +12% |
| IRON Disc Medicine, Inc. | 349,657 | $26.6M | 0.13% | Unchanged |
| GPCR Structure Therapeutics Inc. | 1,432,529 | $24.5M | 0.12% | Unchanged |
| TRDA Entrada Therapeutics, Inc. | 5,072,730 | $23.5M | 0.12% | Unchanged |
| NGNE Neurogene Inc. | 991,691 | $22.7M | 0.11% | Unchanged |
| TRAX First Tracks Biotherapeutics, Inc. | 472,932 | $21.0M | 0.11% | New |
| JBIO Jade Biosciences, Inc. | 1,230,426 | $18.5M | <0.1% | Unchanged |
| ABSI Absci Corporation | 2,134,803 | $17.4M | <0.1% | Unchanged |
| AKTS Aktis Oncology, Inc. | 996,351 | $16.3M | <0.1% | Unchanged |
| TSHA Taysha Gene Therapies, Inc. | 4,004,756 | $15.1M | <0.1% | Unchanged |
| GENB Generate Biomedicines, Inc. | 1,423,602 | $14.8M | <0.1% | Unchanged |
| XENE Xenon Pharmaceuticals Inc. | 370,208 | $13.9M | <0.1% | Unchanged |
| PBLS Parabilis Medicines, Inc. | 500,000 | $13.8M | <0.1% | Unchanged |
| DBVT DBV Technologies S.A. | 1,461,425 | $13.8M | <0.1% | Unchanged |
| RCUS Arcus Biosciences, Inc. | 844,816 | $13.3M | <0.1% | Unchanged |
| DYN Dyne Therapeutics, Inc. | 813,449 | $13.0M | <0.1% | Unchanged |
| TECX Tectonic Therapeutic, Inc. | 607,788 | $12.8M | <0.1% | Unchanged |
| CYTK Cytokinetics, Incorporated | 211,267 | $10.9M | <0.1% | Unchanged |
| SERA Sera Prognostics, Inc. | 5,498,170 | $10.4M | <0.1% | Unchanged |
| CTMX CytomX Therapeutics, Inc. | 4,975,826 | $10.2M | <0.1% | Unchanged |
| AVLN Avalyn Pharma Inc. | 350,000 | $10.0M | <0.1% | Unchanged |
| BNTX BioNTech SE | 119,743 | $9.7M | <0.1% | Unchanged |
| SCTX Scribe Therapeutics Inc. | 688,691 | $9.1M | <0.1% | New |
| EVMN Evommune Inc | 1,234,794 | $8.9M | <0.1% | Added +46% |
| LBRX LB Pharmaceuticals Inc | 200,000 | $8.0M | <0.1% | Unchanged |
| NTLA Intellia Therapeutics, Inc. | 829,053 | $7.9M | <0.1% | Reduced −11% |
| FRNM Freenome, Inc. | 794,908 | $7.9M | <0.1% | New |
| TNGX Tango Therapeutics, Inc. | 333,333 | $7.6M | <0.1% | Unchanged |
| MPLT MapLight Therapeutics, Inc. | 1,166,763 | $7.5M | <0.1% | Added +220% |
| FTH Faeth Therapeutics, Inc. | 803,425 | $7.0M | <0.1% | Reduced −38% |
| QTTB Q32 Bio Inc. | 547,945 | $4.6M | <0.1% | New |
| CERS Cerus Corporation | 2,333,155 | $4.4M | <0.1% | Reduced −64% |
| TARA Protara Therapeutics, Inc. | 1,843,795 | $4.4M | <0.1% | Added +90% |
| AVTX Avalo Therapeutics, Inc. | 550,000 | $3.7M | <0.1% | Unchanged |
| EIKN Eikon Therapeutics, Inc. | 555,555 | $2.6M | <0.1% | Unchanged |
| VTVT vTv Therapeutics Inc. | 148,314 | $2.4M | <0.1% | Unchanged |
| IMNM Immunome, Inc. | 55,306 | $919K | <0.1% | Unchanged |
| SANA Sana Biotechnology, Inc. | 310,483 | $540K | <0.1% | Unchanged |
| TCRX TScan Therapeutics, Inc. | 2,784,792 | $397K | <0.1% | Unchanged |
| TYRA Tyra Biosciences, Inc. | 10,607 | $209K | <0.1% | Unchanged |
| SKYE Skye Bioscience, Inc. | 196,905 | $155K | <0.1% | Unchanged |
| ALGS Aligos Therapeutics, Inc. | 83,055 | $104K | <0.1% | Unchanged |